• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Rare Diseases

    Actuate Receives EMA Orphan Status For Elraglusib In Cancer

    GLOBENEWSWIRE

    Actuate Gets FDA Rare Pediatric Designation for Elraglusib

    GLOBENEWSWIRE

    Actuate Gets FDA Orphan Drug Designation For Elraglusib In Sarcomas

    GLOBENEWSWIRE

    Actuate Therapeutics Receives FDA Orphan Drug Designation for Elraglusib

    GLOBENEWSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.